M. Carrellas

Higher 25‐hydroxyvitamin D levels are associated with greater odds of remission with anti‐tumour necrosis factor‐α medications among patients with inflammatory bowel diseases

J. Korzenik, E. Collins, R. Winter, 2017, Alimentary pharmacology & therapeutics.

Sequential Combination Therapy Versus Monotherapy: A Lack of Benefit in Time to Inflammatory Bowel Disease-Related Surgery

J. Korzenik, E. Barnes, E. Collins, 2016, Digestive Diseases and Sciences.

Inflammatory Bowel Disease Outcomes Following Fecal Microbiota Transplantation for Recurrent C. difficile Infection.

C. Kelly, J. Marchesi, B. Mullish, 2020, Inflammatory bowel diseases.

Low-dose IL-2 for the Treatment of Moderate to Severe Ulcerative Colitis.

S. Snapper, A. Bousvaros, J. Korzenik, 2021, Gastroenterology.

Mucosal Gene Expression in Pediatric and Adult Patients With Ulcerative Colitis Permits Modeling of Ideal Biopsy Collection Strategy for Transcriptomic Analysis.

S. Snapper, A. Bousvaros, J. Korzenik, 2018, Inflammatory bowel diseases.

Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis: A Pilot Clinical Trial.

J. Korzenik, J. Marchesi, Sonia C. Timberlake, 2019, The American journal of gastroenterology.

Fecal Microbiota Transplantation in Patients with Primary Sclerosing Cholangitis: A Pilot Clinical Trial. Authors:

J. Korzenik, J. Marchesi, Sonia C. Timberlake, 2018 .

Effects of Fecal Microbiota Transplantation With Oral Capsules in Obese Patients.

I. García-Pérez, J. Marchesi, K. Kennedy, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Tu1993 Sexual Dysfunction in Women With Inflammatory Bowel Disease: A New IBD-Specific Scale

A. Ananthakrishnan, J. Korzenik, E. Collins, 2015 .

7 – The Icon Study: Inflammatory Bowel Disease and Recurrent Clostridium Difficile Infection: Outcomes After Fecal Microbiota Transplantation

C. Kelly, J. Marchesi, B. Mullish, 2019, Gastroenterology.